Bioregulators

Limitless Parathyroid Bioregulator (Bonothyrk)

$59.99

Description

Amount Per Capsule

Bonothyrk® bioregulator complex A-21 (bovine parathyroid amino acid) – 10mg*

*Daily Value not established

Other ingredients:

Microcrystalline Cellulose, Gelatin and Calcium Stearate

The protein complex in this product is derived from organ meats sourced from EU-reared beef cattle.

Bonothyrk Parathyroid Peptide Bioregulator

Bonothyrk A-21 is a parathyroid peptide bioregulator derived from the parathyroid glands of young animals. It contains natural parathyroid peptides that may help normalize the function of the parathyroid glands by reducing peptide deficiency and restoring protein synthesis within cells. Research has indicated its potential in addressing conditions such as hyperparathyroidism, osteoporosis, and muscle weakness by improving the functional activity of the parathyroid glands. The gentle and gradual performance of these peptides suggests promising applications in the study of metabolic and musculoskeletal health.

Potential Research Applications of Bonothyrk®

Bonothyrk peptide complex A-21 is a natural parathyroid bioregulator that has shown promise in various research applications. Researchers may find the following areas particularly relevant for further investigation.

The parathyroid glands regulate calcium homeostasis, a critical process for muscular contractions, neurological signaling, skeletal integrity, and metabolic equilibrium. Primary hyperparathyroidism, a disorder characterized by excessive parathyroid hormone secretion, exhibits an increased prevalence in elderly populations, afflicting up to 1% of individuals and precipitating complications like osteoporosis and cognitive impairment.

Current therapeutic modalities are constrained, often accompanied by substantial adverse effects, underscoring the necessity for novel interventions.

Bone Health: Bonothyrk® shows promise in regulating calcium and phosphate homeostasis—key factors influencing bone density and integrity. Its potential impact on skeletal health could prove invaluable for advancing research into osteoporosis and other bone disorders.

Muscle Function: Preliminary studies suggest that Bonothyrk® might improve muscle function and reduce muscle weakness. This area of research could be valuable for understanding muscle disorders and developing new treatments.

Metabolic Regulation: Bonothyrk® has shown potential in normalizing parathyroid gland function, which plays a role in overall metabolic health. Researchers might explore its effects on metabolic disorders, including hyperparathyroidism and hypocalcemia.

Nervous System Support: The peptide’s role in maintaining calcium levels could be beneficial for nervous system health. Further research could investigate its potential in treating neurological conditions linked to calcium imbalances.

Kidney Health: There is evidence that Bonothyrk® may help in managing conditions like urolithiasis (kidney stones). This could open new avenues for research into kidney health and the prevention of stone formation.

Muscle Spasms and Numbness: Studies have shown that Bonothyrk® might alleviate symptoms such as muscle spasms and numbness. This could be an important area for research into neuromuscular disorders and their management.

Therapeutic Areas of Interest

  • Osteoporosis
  • Muscle weakness
  • Hyperplasia of the parathyroid
  • Numbness
  • Muscle spasms

Similar Products

Scroll to Top